Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Researchers provide a framework for unifying and categorizing neurodegenerative diseases based on eight hallmarks

Researchers provide a framework for unifying and categorizing neurodegenerative diseases based on eight hallmarks

UTHSC researchers secure $308,000 grant from Department of Defense for dementia study

UTHSC researchers secure $308,000 grant from Department of Defense for dementia study

FAU collaborates with Delray Medical Center, Insightec to fight against Alzheimer's disease

FAU collaborates with Delray Medical Center, Insightec to fight against Alzheimer's disease

Scientists discover how a "poisoned" form of protein could spur cancer formation

Scientists discover how a "poisoned" form of protein could spur cancer formation

New measure of physical balance could help identify people with Alzheimer's risk

New measure of physical balance could help identify people with Alzheimer's risk

Major funding boost for research on neurodegenerative diseases

Major funding boost for research on neurodegenerative diseases

Social and economic disadvantage may explain the higher risk of dementia in women

Social and economic disadvantage may explain the higher risk of dementia in women

Active compound in Lion’s Mane mushroom improves nerve growth and memory

Active compound in Lion’s Mane mushroom improves nerve growth and memory

Exploring two small molecules for the disintegration of alpha-synuclein fibrils

Exploring two small molecules for the disintegration of alpha-synuclein fibrils

Fructose may be fueling the formation of Alzheimer’s disease

Fructose may be fueling the formation of Alzheimer’s disease

Active compound from edible mushrooms boosts nerve growth and enhances memory

Active compound from edible mushrooms boosts nerve growth and enhances memory

Researchers discover new neurological condition characterized by issues with motor coordination and speech

Researchers discover new neurological condition characterized by issues with motor coordination and speech

Disruptions to the normal fllow of brain fluid linked to neurological conditions

Disruptions to the normal fllow of brain fluid linked to neurological conditions

Novel nuclear medicine imaging protocol cuts costs and radiation exposure for Alzheimer's patients

Novel nuclear medicine imaging protocol cuts costs and radiation exposure for Alzheimer's patients

Changes in brain aerobic glycolysis reflect aging-related pathologies in Alzheimer’s

Changes in brain aerobic glycolysis reflect aging-related pathologies in Alzheimer’s

Professor Sara Linse presents new data on protein interactions in Alzheimer’s disease using the Fluidity One-W at FEBS 2019

Professor Sara Linse presents new data on protein interactions in Alzheimer’s disease using the Fluidity One-W at FEBS 2019

Expert work group examines and redefines “clinical meaningfulness” in Alzheimer’s

Expert work group examines and redefines “clinical meaningfulness” in Alzheimer’s

What do gut microbiota have to do with Alzheimer's and dementia?

What do gut microbiota have to do with Alzheimer's and dementia?

Changes in the cerebral neural network could function as a biomarker for neurocognitive disorders

Changes in the cerebral neural network could function as a biomarker for neurocognitive disorders

Researchers develop a cell line to address the challenges facing cellular modeling of disease

Researchers develop a cell line to address the challenges facing cellular modeling of disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.